Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.40 +0.01 (+2.73%)
As of: Oct 21, 2026 · 1:16 PM EDT

Biodexa Pharmaceuticals (BDRX) Finished Goods (2015 - 2017)

Updated

Biodexa Pharmaceuticals (BDRX) reported Finished Goods of $1.25 million for the quarter ended Dec 31, 2017, up 23.0% from $1.02 million a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Finished Goods (2015 - 2017) Analysis & Trends

As of Dec 31, 2017, Biodexa Pharmaceuticals posted Finished Goods of $1.21 million, up 9.4% from the prior year.

  • By year, Finished Goods came in at $1.11 million in the year ended Dec 31, 2016 (+216.5%) and $350,169 in the year ended Dec 31, 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.69 Bn 1,103.27 Bn 19.71 Bn
2 Johnson & Johnson 616.29 Bn 534.82 Bn 17.26 Bn
3 AbbVie 500.86 Bn 473.97 Bn 12.70 Bn
4 Merck 366.77 Bn 321.15 Bn 12.21 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn
7 Amgen 235.52 Bn 190.92 Bn 7.24 Bn
8 Gilead Sciences 190.49 Bn 164.69 Bn 6.22 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn
10 Biodexa Pharmaceuticals 3,926.57 -23.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 1.26 Mn
Dec 31, 2016 1.00 Mn
Dec 31, 2015 339,359.82
API Access

Biodexa Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=BDRX&period=max&api_key=YOUR_API_KEY